Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul 3:2:20.
doi: 10.1186/2052-8426-2-20. eCollection 2014.

Making sense of how HIV kills infected CD4 T cells: implications for HIV cure

Affiliations
Review

Making sense of how HIV kills infected CD4 T cells: implications for HIV cure

Nathan W Cummins et al. Mol Cell Ther. .

Abstract

Defining how HIV does, and does not, kill the host CD4 T cell that it infects is of paramount importance in an era when research is approaching a cure for infection. Three mutually exclusive pathways can lead to the death of HIV-infected cells during the HIV life cycle, before, coincident and after HIV integration and consequently may affect viral replication. We discuss the molecular mechanism underlying these pathways, the evidence supporting their roles in vivo, and contemplate how understanding these pathways might inform novel approaches to promote viral cure of HIV.

Keywords: Apoptosis; Casp8p41; Caspase 1; Cure; DNA-PK; HIV; IFI16; Inflammation; Pyroptosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathways of CD4 T cell death in HIV infection. Depicted are the described pathways for both uninfected and infected CD4 T cell death in the context of HIV infection and whether progeny virions are produced as a result of the pathway. Examples are provided describing the pathogenicity of the pathway in relevant in vitro models. Specific in vivo support of the pathwaysm biologic relevance are also described. Theoretical ways to inhibit the described pathways are conjectured. References [–, –44].

References

    1. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25. doi: 10.1097/QCO.0b013e32835ba6b1. - DOI - PubMed
    1. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, Paredes R, Bakowska E, Engsig FN, Phillips A. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. Aids. 2013;27(6):973–979. doi: 10.1097/QAD.0b013e32835cae9c. - DOI - PubMed
    1. Desvarieux M, Boccara F, Meynard JL, Bastard JP, Mallat Z, Charbit B, Demmer RT, Haddour N, Fellahi S, Tedgui A, Cohen A, Capeau J, Boyd A, Girard PM. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy. Aids. 2013;27(16):2603–2614. doi: 10.1097/QAD.0b013e3283634819. - DOI - PubMed
    1. Maloberti A, Giannattasio C, Dozio D, Betelli M, Villa P, Nava S, Cesana F, Facchetti R, Giupponi L, Castagna F, Sabbatini F, Bandera A, Gori A, Grassi G, Mancia G. Metabolic syndrome in human immunodeficiency virus-positive subjects: prevalence, phenotype, and related alterations in arterial structure and function. Metab Syndr Relat Disord. 2013;11(6):403–411. doi: 10.1089/met.2013.0008. - DOI - PubMed
    1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67. doi: 10.1016/S0140-6736(07)61050-2. - DOI - PubMed

LinkOut - more resources